Display options
Share it on

Curr Gene Ther. 2015 Apr 09;15(3):245 - 254. doi: 10.2174/1566523215666150126120327.

RETRACTED: Novel and safer self-inactivating vectors for gene therapy of Wiskott-Aldrich Syndrome.

Current gene therapy

Emanuele G. Coci, Tobias Maetzig, Daniela Zychlinski, Michael Rothe, Julia D. Suerth, Christoph Klein, Axel Schambach

Affiliations

  1. Institute of Experimental Hematology, Hannover Medical School, Hannover, Germany
  2. Dr. von Hauner Children´s Hospital, Ludwig-Maximilians University, Munich, Germany
  3. Division of Hematology/Oncology, Boston Children’s Hospital, Harvard Medical School, MA, USA

PMID: 25963902 DOI: 10.2174/1566523215666150126120327

Abstract

The article entitled “Novel and safer self-inactivating vectors for gene therapy of Wiskott-Aldrich Syndrome”, by E. G. Coci1, T. Maetzig, D. Zychlinski, M. Rothe, J. D. Suerth, C. Klein and A.Schambach has been retracted, on the request of the authors.

Kindly see Bentham Science Policy on Article retraction at the link given below:

(https://www.benthamscience.com/journals/current-medical-imaging/author-guidelines/).

It is a pre-requisite for authors to declare explicitly that their work is original and has not been published elsewhere. Authors are advised to properly cite the original source to avoid plagiarism and copyright violation. As such this article represents a severe abuse of the scientific publishing system. Bentham Science Publishers takes a very strong view on this matter and apologizes to the readers of the journal for any inconvenience this may cause.

© 2015 Bentham Science Publishers

Publication Types